Research in the Journal of Health Economics estimates the costs of developing a new medication.
Read More
A study in the Journal of Health Economics once again indicates that disease management programs have a hard time creating spending reductions that cover the cost of the program.
Read More
A survey from Manhattan Research examines drug company sales representatives interactions with physicians.
Read More
Lots of CRO deals lately. Now Evotec, a Germany-based vendor focusing on pre-clinical development, is acquiring Aptuit, which provides similar services, for $300 million.
http://www.fiercebiotech.com/cro/evotec-to-fill-pre-ind-service-gap-300m-aptuit-buy?mkt_tok=eyJpIjoiWm1ObFlUQm1NalUxT1RrNCIsInQiOiJ6UENNRjVhazRoS2Yycjg2XC9ydEtXRmJRVDZQRzJMNEJ2UGdqQlwvYTBvS1JDWnpzZHFQRTN0TEZueXBFUlcyWFZqWDBcL3VsSXhiSWpZNWdnRVwvbW1LVk8yVFN0Tm5lN29CekJMdm5tdkhOUFdNRWU1XC9FamN1bnVhS3BEbWc3K0NCIn0%3D&mrkid=635530&utm_medium=nl&utm_source=internalContract research firm Icon is buying Mapi, which provides data and analysis on the economic and other outcome benefits of drugs.
http://www.fiercebiotech.com/cro/icon-enhances-commercialization-arm-mapi-buy-reports-record-q2?mkt_tok=eyJpIjoiTldaaE5tUTBNREkxTURFMCIsInQiOiIrcHNGbUhXcUZTcjdGMmpwakxRRjdMZUU3QVVcL1RSRmlHcVo3Vm5UWjZyY2F2SDN3TXdXOTBpVmxsRVJNREl0TFFmQ1hhMHh5XC9lRzJEaFBiQ1NoTGw4Z3dJYjFBRmFXU0pCY2YzWlwvUFkxeFVRajdLRCtPRjRRbXcySlRUSzVHQyJ9&mrkid=635530&utm_medium=nl&utm_source=internalResearch carried by the Journal of the American Medical Association looks at the impact of social factors and medical risk on valued-based purchasing program performance.
Read More
In a study of medical home implementation at federally qualified health centers, researchers found that costs increased.
Read More
This is what happens when you don't have a fruit in your company name, you get sold. Nursing home pharmacy chain Pharmerica is being bought by a PE firm for $1.4 billion. No word yet on whether the name will be changed to Pharnana.
https://www.pehub.com/2017/08/kkr-to-buy-pharmerica-corp-for-1-4-bln/Must be a fruity day, as Limelight Health garners $7 million in new funding for its employee health benefits enrollment, etc. software. What's next--a company named Apple?
http://www.prnewswire.com/news-releases/limelight-health-raises-7-million-to-expand-employee-benefits-quote-to-enrollment-platform-300497409.htmlAbout this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.